Skip to main content
. 2002 Nov;161(5):1815–1823. doi: 10.1016/S0002-9440(10)64458-6

Table 2.

PCR Primers

CD83 5′-GTTATTGGAGGGTGGTGAAGAGAGG-3′
5′-GTGAGGAGTCACTAGCCCTAAATGC-3′
CCL18 5′-GGTGTCATCCTCCTAACCAAG-3′
5′-GGAAAGGGGAAAGGATGATA-3′
DC-SIGN 5′-GATTCCGACAGACTCGAGGA-3′
5′-CCTACAGCTTGGATTTCTCT-3′
CD1a 5′-CAATGCAGACGGGCTCAAG-3′
5′-GAATTGCAGTTTGAATATCCTTTTG-3′
IL-12p40 5′-TCACAAAGGAGGCGAGGTTCTA-3′
5′-CATGACCTCAATGGGCAGACTC-3′
CCL21 5′-CCCCAGGACCCAAGGCAGTGATGGA-3′
5′-TGCAAGAGGACTGAGCGGTCACA-3′
CCL19 5′-CCAATGATGCTGAAGACTGCT-3′
5′-GCCAAGATGAAGCGCCGCA-3′
β-actin 5′-ATGGCCACGGCTGCTTCCAGC-3′
5′-CATGGTGGTGCCGCCAGACAG-3′
HHS Vulnerability Disclosure